Title of Invention Sample Clauses
Title of Invention. The listing of Patent Licenses (as defined in the Collateral Agreement) should include: (a) Name and Address of Licensee/Licensor; (b) Date; (c) List of each Patent Licensed/Assigned; and (d) Description of product to which license/assignment applies
Title of Invention. The listing of Patent (as defined in the Collateral Agreement) applications should include: (a) Application Number; (b) Filing Date; and (c)
Title of Invention. Edible Pet Chew with Thermo-processed Shell and Cold-formed Filling First Named Inventor/Applicant Name: Bxxxx Xxxxxx Customer Number: 167383 Filer: Lxxxx X Xxxxx Attorney Docket Number: CCon-2UTIL Receipt Date: 16-JUL-2020 Time Stamp: 13:21:34 Application Type: Utility under 35 USC 111(a) Submitted with Payment yes Payment Type CARD Payment was successfully received in RAM $785 RAM confirmation Number E20207FD23294677 Deposit Account Authorized User The Director of the USPTO is hereby authorized to charge indicated fees and credit any overpayment as follows: d507e51f4db57877278f7824c32e614985e5829d
Title of Invention. Treatment of human male infertility by use of teneurin C-terminal associated peptide (TCAP)-1
Title of Invention. Treatment of insulin-resistant hyperglycemia by teneurin C-terminal associated peptide-1 administration
2. a) University of Toronto Inventors Individuals intimal to the University who have made an inventive contribution to this Invention i.e. faculty, students, postdocs, staff etc. Attach extra sheet if necessary: SURNAME, GIVEN NAMES UNIVERSITY PERSONNEL NO. DEPARTMENT (List any cross appointments or affiliated institutions) AFFILIATION EMAIL ADDRESS CONTACT INFORMATION (mailing address phone, fax) Xxxxxxx Xxxxx Xxxx 000000000 Cell and Systems Biology Professor David.xxxxxxx@ Xxxxxxxx.xx Tel: cell: 000 000 0000, home: 000 000 0000 Address: 000 Xxxxx Xxxxxx, Stouffville, Ontario, L4A 1K6 b) External Inventors Non-University of Toronto Individuals who have made an inventive contribution to the Invention. i.e. sponsor employees, academic collaborators, etc. List name, organization and e-mail address. not applicable For Research Services use only: Date Received: JAN 16 2014 DISCLOSURE REFERENCE NO: 10002701 Version: 2011.09.08
Title of Invention. Country Filing Date Xxxxxx Case Number
Title of Invention. The listing of Copyrights (as defined in the Collateral Agreement) should include: (a) Registration Number; (b) Registration Date; and (c) Title as listed in Registration.
Title of Invention. The listing of Patent Licenses (as defined in the Collateral Agreement) should include: (a) Name and Address of Licensee/Licensor; (b) Date; (c) List of each Patent Licensed/Assigned; and (d) Description of product to which license/assignment applies 6. The listing of Copyrights (as defined in the Collateral Agreement) should include: (a) Registration Number; (b) Registration Date; (c) Title as listed in Registration; (d) Publication Date; (e) Creation Date; (f) Author; and(g) Subject Matter Covered.
Title of Invention. The listing of Copyrights should include: (a) Registration Number; (b) Registration Date; (c) Title as listed in Registration; (d) Publication Date; (e) Creation Date; and (f) Owner.
Title of Invention. LOMACEN.022PR Use of 4-Hydroxy NSAIDs for Treatment of Disease THIS LICENSE AGREEMENT (this “Agreement”) is made and entered into effective as of December 7, 2000, by and between Myriad Genetics, Inc., a Delaware corporation, having its principal place of business at 000 Xxxxxx Xxx, Xxxx Xxxx Xxxx, Xxxx 00000 (“Myriad”), and Encore Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at 0000 Xxxx Xxxx Xxxxxx, Xxxx, Xxxxxxxxxx 00000 (“Licensor”).